A Phase II Trial of Weight-based Dosing for Dense Weekly Paclitaxel and Carboplatin in Overweight Patients With a BSA > 2.0
Latest Information Update: 07 Aug 2020
At a glance
- Drugs Carboplatin (Primary) ; Paclitaxel (Primary)
- Indications Gynaecological cancer
- Focus Therapeutic Use
- 03 Aug 2020 Status changed from active, no longer recruiting to discontinued.
- 28 Feb 2019 Status changed from recruiting to active, no longer recruiting.
- 08 Jan 2019 Planned primary completion date changed from 1 Dec 2018 to 1 Mar 2019.